| Michelle A Ludlow, SLP | |
|
808 Mill Lake Rd, Fort Wayne, IN 46845-6400 | |
| (260) 338-1241 | |
| (260) 338-1231 |
| Full Name | Michelle A Ludlow |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 808 Mill Lake Rd, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003020959 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22003960A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle A Ludlow, SLP 717 Beech Dr, Gas City, IN 46933-1242 Ph: (260) 338-1241 | Michelle A Ludlow, SLP 808 Mill Lake Rd, Fort Wayne, IN 46845-6400 Ph: (260) 338-1241 |
News Archive
Prolonged stress and anxiety during childhood is a risk factor for developing anxiety disorders and depression later in life. Now, Stanford University School of Medicine researchers have shown that by measuring the size and connectivity of a part of the brain associated with processing emotion - the amygdala - they can predict the degree of anxiety a young child is experiencing in daily life.
Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).
Codman Neuro has launched the CODMAN ENTERPRISE 2 Vascular Reconstruction Device, the latest generation of the company's self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils during and after the procedure.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
Facing potential financial penalties from Medicare, more hospitals are changing decades-old practices that contribute to the din.
› Verified 9 days ago
Josie Lyn Johnson, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5250 Heritage Pkwy, Fort Wayne, IN 46835 Phone: 260-209-6279 | |
Linda Sue Sickman, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1717 Maplecrest Rd, Fort Wayne, IN 46815 Phone: 260-493-0012 | |
Jennifer Lynn Garrett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6329 Mapledowns Dr, Fort Wayne, IN 46835 Phone: 260-433-7903 | |
Jennifer Wilson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 808 Mill Lake Rd, Fort Wayne, IN 46845 Phone: 260-338-1241 Fax: 260-338-1231 | |
Mrs. Toni Walker Blackwood, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1923 Brandywine Trl, Fort Wayne, IN 46845 Phone: 260-637-3117 | |
Mrs. Kimberly A Griffith, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6205 Constitution Dr, Fort Wayne, IN 46804 Phone: 260-438-3586 Fax: 877-992-0273 |